LinkGevity receives BBC news coverage
LinkGevity's work featured on the BBC. The coverage highlights the growing momentum behind the company's approach, alongside insights from leading experts in the field.
As Prof. Narain Moorjani, Clinical Lead for Cardiac Surgery at Royal Papworth Hospital NHS Foundation Trust, put it: LinkGevity is the first company to attempt to specifically block the endpoint of necrosis, which is what makes the plans for this trial so exciting.
Read the full online report - https://www.bbc.com/news/articles/c5yde4v5x0do
